Twitter

Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C

Condition:   Advanced Gastrointestinal Malignancies
Intervention:   Drug: MLN0264
Sponsor:   Millennium Pharmaceuticals, Inc.
Not yet recruiting – verified April 2012

Continued here: Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C




Comments are closed.